Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

2.50
Hdl Handle:
http://hdl.handle.net/10541/620647
Title:
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.
Authors:
Armstrong, A; Antonarakis, E; Taplin, M; Kelly, W; Beltran, H; Fizazi, K; Dahut, W; Shore, N; Slovin, S; George, D; Carducci, M; Corn, P; Danila, D; Dreicer, R; Heath, E; Rathkopf, D; Liu, G; Nanus, D; Stein, M; Smith, M; Sternberg, C; Wilding, G; Nelson, P; Halabi, S; Kantoff, P; Clarke, Noel W ( 0000-0001-7776-8059 ) ; Evans, C; Heidenreich, A; Mottet, N; Gleave, M; Morris, M; Scher, H
Affiliation:
Department of Medicine, Duke Cancer Institute, Durham NC, United StatesDepartment of Oncology, Johns Hopkins University, Baltimore MD, United States
Citation:
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. 2017, Ann Oncol
Journal:
Annals of Oncology
Issue Date:
23-Oct-2017
URI:
http://hdl.handle.net/10541/620647
DOI:
10.1093/annonc/mdx648
PubMed ID:
29088323
Type:
Article
Language:
en
ISSN:
1569-8041
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorArmstrong, Aen
dc.contributor.authorAntonarakis, Een
dc.contributor.authorTaplin, Men
dc.contributor.authorKelly, Wen
dc.contributor.authorBeltran, Hen
dc.contributor.authorFizazi, Ken
dc.contributor.authorDahut, Wen
dc.contributor.authorShore, Nen
dc.contributor.authorSlovin, Sen
dc.contributor.authorGeorge, Den
dc.contributor.authorCarducci, Men
dc.contributor.authorCorn, Pen
dc.contributor.authorDanila, Den
dc.contributor.authorDreicer, Ren
dc.contributor.authorHeath, Een
dc.contributor.authorRathkopf, Den
dc.contributor.authorLiu, Gen
dc.contributor.authorNanus, Den
dc.contributor.authorStein, Men
dc.contributor.authorSmith, Men
dc.contributor.authorSternberg, Cen
dc.contributor.authorWilding, Gen
dc.contributor.authorNelson, Pen
dc.contributor.authorHalabi, Sen
dc.contributor.authorKantoff, Pen
dc.contributor.authorClarke, Noel Wen
dc.contributor.authorEvans, Cen
dc.contributor.authorHeidenreich, Aen
dc.contributor.authorMottet, Nen
dc.contributor.authorGleave, Men
dc.contributor.authorMorris, Men
dc.contributor.authorScher, Hen
dc.date.accessioned2017-11-21T21:57:01Z-
dc.date.available2017-11-21T21:57:01Z-
dc.date.issued2017-10-23-
dc.identifier.citationNaming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. 2017, Ann Oncolen
dc.identifier.issn1569-8041-
dc.identifier.pmid29088323-
dc.identifier.doi10.1093/annonc/mdx648-
dc.identifier.urihttp://hdl.handle.net/10541/620647-
dc.language.isoenen
dc.rightsArchived with thanks to Annals of oncology : official journal of the European Society for Medical Oncologyen
dc.titleNaming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medicine, Duke Cancer Institute, Durham NC, United StatesDepartment of Oncology, Johns Hopkins University, Baltimore MD, United Statesen
dc.identifier.journalAnnals of Oncologyen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.